Caroline Loewy, Director at CymaBay Therapeutics, holds ― shares in CymaBay Therapeutics (Ticker: CBAY), holds ― shares in Aptose Biosciences (Ticker: APTO), holds 3.75K shares in Phasebio Pharmaceuticals (Ticker: PHASQ). Most recently, Caroline Loewy ― shares of CymaBay Therapeutics on ― for an estimated value of ―.